Cannara Biotech Inc. (LOVFF) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Cannara Biotech Inc.

LOVFF

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

42M

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Dec 2024

42M

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Dec 2024

0.47USD

0.00 ( 0.00%)

Market Open

Relative Strenght

Volume Buzz

58%

Earning Acce

Dist 52w H.

40%

Overview Chart

Quote Panel

Updated October 24, 2024

1W -2.25 % 1M 17.25 % 3M 13.56 % 1Y -34.43 %

Key Metrics

Market Cap
41.91M
Shares Outstanding
90.02M
Share in Float
43.80M
Dividende
0

Earning Date
05 Dec 2024
Price Target
0.4656
Average Volume
1402
Beta
1.082

Range
0.387-0.775
Industry
Drug Manufacturers - Specialty & Generic
Website
https://cannara.ca
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.77x

P/S Ratio

0.73x

P/B Ratio

0.6

Debt/Equity

6.9%

Net Margin

$0.0

EPS

How LOVFF compares to sector?

P/E Ratio

Relative Strength

LOVFF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

NA
vs -0.01

Q2.22

+17%

0.02
vs 0.02

Q3.22

N/A

NA
vs 0.01

Q4.22

N/A

NA
vs -0.00

Q1.23

N/A

-0.01
vs NA

Q2.23

+71%

0.04
vs 0.02

Q3.23

N/A

NA
vs NA

Q4.23

N/A

0.02
vs NA

Q1.24

N/A

-0.03
vs -0.01

Q2.24

-100%

NA
vs 0.04

Sales Growth

YoY

Current

Estimates

Q1.22

+229%

7.4M vs 2.3M

Q2.22

+41%

10.1M vs 7.2M

Q3.22

+89%

11.8M vs 6.2M

Q4.22

+57%

10.3M vs 6.6M

Q1.23

+76%

13M vs 7.4M

Q2.23

+57%

15.8M vs 10.1M

Q3.23

+55%

18.3M vs 11.8M

Q4.23

+89%

19.5M vs 10.3M

Q1.24

+51%

19.7M vs 13M

Q2.24

+23%

19.5M vs 15.8M

Return on Equity

QoQ

Q3.22

+4%

0.04
vs 0.02

Q4.22

+0%

0
vs 0.04

Q1.23

-1%

-0.01
vs 0

Q2.23

+4%

0.04
vs -0.01

Q3.23

+6%

0.06
vs 0.04

Q4.23

+3%

0.03
vs 0.06

Q1.24

-4%

-0.04
vs 0.03

Q2.24

+2%

0.02
vs -0.04

Institutionnal Ownership

Earnings Growth

Latest News

investorplace.com

7 hours ago

The 7 Most Undervalued Cannabis Stocks to Buy in December

globenewswire.com

8 hours ago

Cannara Biotech Reports Q3 2024 Financial Results

prnewswire.com

8 hours ago

Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion

prnewswire.com

8 hours ago

Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")

prnewswire.com

10 hours ago

Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024

prnewswire.com

15 hours ago

Cannara Biotech Reports Q2 2024 Financial Results

New Feature Coming Soon, Stay Tuned!

Company Description

N/A

0.77x

0.73x

0.6

6.9%

$0.0

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!